BDTX BLACK DIAMOND THERAPEUTICS INC Other Situations 8-K Filing 2023 - Annual Meeting of Stockholders Black Diamond Therapeutics held its 2023 Annual Meeting of Stockholders, where three Class III directors were elected and the appointment of PricewaterhouseCoopers LLP as the independent registered public accounting firm was ratified.Get access to all SEC 8-K filings of the BLACK DIAMOND THERAPEUTICS INC